U.S. markets closed

PPD, Inc. (PPD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
46.94-0.01 (-0.02%)
At close: 4:00PM EDT
46.94 0.00 (0.00%)
After hours: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close46.95
Bid46.90 x 3100
Ask46.97 x 800
Day's Range46.90 - 47.01
52 Week Range31.54 - 47.08
Avg. Volume1,319,356
Market Cap16.491B
Beta (5Y Monthly)N/A
PE Ratio (TTM)65.56
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
1% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PPD

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • PPD, Inc.
    Analyst Report: PPD, Inc.PPD is a global contract research organization that provides clinical trial and laboratory services to pharmaceutical, device, and diagnostic firms. The clinical development services segment offers outsourced trial services, spanning early- and late-stage trials, as well as peri- and post-approval trials, and the laboratory services segment includes both advanced lab testing and central lab services. The company was taken private in 2011 and went public again in 2020.. Thermo Fisher Scientific announced it will acquire PPD for $17.4 billion, which is scheduled to close by the end of 2021.
    Fair Value
    Economic Moat
    3 months agoMorningstar
View more
  • Insider Monkey

    Hedge Funds Are Piling Into PPD, Inc. (PPD)

    In this article we will take a look at whether hedge funds think PPD, Inc. (NASDAQ:PPD) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get tips from […]

  • Insider Monkey

    George Soros Stock Portfolio: Top 10 Stock Picks

    In this article, we discuss George Soros’ stock portfolio: top 10 stock picks. If you want to skip our detailed analysis of these stocks, go directly to George Soros Stock Portfolio: Top 5 Stock Picks. George Soros, also known as, “The Man Who Broke the Bank of England”, is a Hungarian-born American billionaire, investor, and […]

  • Insider Monkey

    George Soros Stock Portfolio: Top 10 Large-Cap Stock Picks

    In this article, we discuss the 10 top large-cap stock picks of George Soros. If you want to skip our detailed analysis of these stocks, go directly to George Soros Stock Portfolio: Top 5 Large-Cap Stock Picks. In an era of soaring market valuations and growth-focused investment portfolios, old-school investors have been pushed to the […]